Clinical Trial Update: 177Lu-PSMA-EB-01 in Patients With Metastatic Castration-resistant Prostate Cancer [NA]

View source ↗

Summary

Update on a clinical trial evaluating 177Lu-PSMA-EB-01 in patients with metastatic castration-resistant prostate cancer; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• 177Lu-PSMA-EB-01 (Lutetium-177 PSMA-EB-01)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Metastatic Castration-resistant Prostate Cancer | NA | Status: RECRUITING